Delivery Order SPE2DB22D2211-SPE2DB25FSELW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $17,164.32 for the supply of Clobazam 10 mg tablets (100-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is not set-aside and was competitively awarded under the Defense Logistics Agency's Medical Supply Chain, which funds federal medical procurement for military and veteran...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,711.98 firm fixed price delivery order is for the supply of 4,567,393,696 units of clobazam 10 mg tablets. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,051.36 by the Defense Logistics Agency (DLA) for the supply of Clobazam 10 mg tablets (100 count) to be performed at the contractor's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 20, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,567.49, is for the provision of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- The Defense Logistics Agency awarded a $3,196.76 delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) with an ultimate completion date of August 20, 2025. This non-competitive delivery order represents a firm fixed price purchase executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,622.52 on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $4,417.96 firm fixed-price delivery order is for the supply of 4,564,803,704 tablets of the pharmaceutical drug clobazam 10 mg. The contract has a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.31 firm-fixed-price delivery order is for the supply of 4,567,675,699 units of the pharmaceutical drug clobazam 10 mg tablets. The contract has an ultimate completion date of March 25, 2025 and is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSELWDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,279.83 by the Defense Logistics Agency for 100 tablets of Clobazam 10 mg. The contract, awarded September 8, 2025, with an ultimate completion date of September 9, 2025, is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The Defense Logistics Agency utilizes comprehensive pharmaceutical prime vendor contracts to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal medical facilities. AmerisourceBergen's IDC vehicle enables the company to supply an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition positions it as a critical vendor for federal pharmaceutical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/8/25 |